Nektar Therapeutics Reports First Quarter 2023 Financial Results

SAN FRANCISCO, May 9, 2023 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2023. Cash and investments in marketable securities at March 31, 2023, were $456.8 million as compared to $505.0 million at December 31,…